Trials / Completed
CompletedNCT02453152
Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- Male
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
This study is a longitudinal study evaluating the severity and progression of respiratory muscle function in patients with X-Linked Myotubular Myopathy (XLMTM) aged 0-14.
Detailed description
Subjects aged 0-7 will be evaluated every six months for a total of three evaluations (Baseline, Six-Month Visit, Twelve-Month Visit). Subjects aged 8-14 will be evaluated every twelve months for a total of two evaluations (Baseline, Twelve-Month Visit). Evaluations include medical history, physical exam, respiratory muscle tests, a qualitative interview related to the child's function and use of respiratory aids, and quality of life assessments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | History and physical | Subjects will undergo a physical exam and medical history review, including review of genetic test results. |
| OTHER | Tidal breathing | Subjects' breathing patterns will be evaluated at rest and at reduced/eliminated ventilator support. |
| OTHER | Maximal respiratory pressures | Subjects' strongest inspiratory and expiratory pressures will be measured. |
| OTHER | Peak cough flow | Subjects' strongest coughs will be measured. |
| OTHER | Pediatric Evaluation of Disability Inventory | Assesses the functional capabilities of children with disabilities. |
| OTHER | PedsQL Multidimensional Fatigue Scale | Assesses general fatigue, sleep/rest fatigue, and cognitive fatigue. |
| OTHER | Review of ventilation requirements | Subjects's use of mechanical ventilation reviewed by the study team. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
- First posted
- 2015-05-25
- Last updated
- 2021-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02453152. Inclusion in this directory is not an endorsement.